197 related articles for article (PubMed ID: 31969193)
41. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
[TBL] [Abstract][Full Text] [Related]
42. Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of alphavbeta3-antagonists in rat: limited role of P-glycoprotein.
Prueksaritanont T; Meng Y; Ma B; Leppert P; Hochman J; Tang C; Perkins J; Zrada M; Meissner R; Duggan ME; Lin JH
Xenobiotica; 2002 Mar; 32(3):207-20. PubMed ID: 11958560
[TBL] [Abstract][Full Text] [Related]
43. Tetrahydroxy Stilbene Glucoside Alleviates High Glucose-Induced MPC5 Podocytes Injury Through Suppression of NLRP3 Inflammasome.
Li J; Wang B; Zhou G; Yan X; Zhang Y
Am J Med Sci; 2018 Jun; 355(6):588-596. PubMed ID: 29891042
[TBL] [Abstract][Full Text] [Related]
44. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD
Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904
[TBL] [Abstract][Full Text] [Related]
45. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
[TBL] [Abstract][Full Text] [Related]
47. Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil.
Choi MK; Song IS
J Pharm Pharmacol; 2012 Aug; 64(8):1074-83. PubMed ID: 22775210
[TBL] [Abstract][Full Text] [Related]
48. Role of intestinal efflux transporters in the intestinal absorption of methotrexate in rats.
Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
J Pharm Pharmacol; 2007 Sep; 59(9):1263-70. PubMed ID: 17883898
[TBL] [Abstract][Full Text] [Related]
49. 2,3,5,4'-tetrahydroxystilbence-2-O-β-D-glucoside attenuates hepatic steatosis via IKKβ/NF-κB and Keap1-Nrf2 pathways in larval zebrafish.
Wang C; Hu NH; Yu LY; Gong LH; Dai XY; Peng C; Li YX
Biomed Pharmacother; 2020 Jul; 127():110138. PubMed ID: 32387861
[TBL] [Abstract][Full Text] [Related]
50. Mechanistic analysis for drug permeation through intestinal membrane.
Hayashi M; Tomita M
Drug Metab Pharmacokinet; 2007 Apr; 22(2):67-77. PubMed ID: 17495413
[TBL] [Abstract][Full Text] [Related]
51. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
Abuasal BS; Bolger MB; Walker DK; Kaddoumi A
Mol Pharm; 2012 Mar; 9(3):492-504. PubMed ID: 22264132
[TBL] [Abstract][Full Text] [Related]
52. Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis.
Lin P; Lu J; Wang Y; Gu W; Yu J; Zhao R
PLoS One; 2015; 10(10):e0140346. PubMed ID: 26474417
[TBL] [Abstract][Full Text] [Related]
53. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
[TBL] [Abstract][Full Text] [Related]
54. Investigation of the functional role of P-glycoprotein in limiting the oral bioavailability of lumefantrine.
Wahajuddin ; Raju KS; Singh SP; Taneja I
Antimicrob Agents Chemother; 2014; 58(1):489-94. PubMed ID: 24189249
[TBL] [Abstract][Full Text] [Related]
55. pH dependent uptake of loperamide across the gastrointestinal tract: an in vitro study.
Crowe A; Wong P
Drug Dev Ind Pharm; 2004 May; 30(5):449-59. PubMed ID: 15244080
[TBL] [Abstract][Full Text] [Related]
56. Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.
Chen Y; Xue F; Xia G; Zhao Z; Chen C; Li Y; Zhang Y
Food Funct; 2019 Aug; 10(8):5215-5227. PubMed ID: 31384856
[TBL] [Abstract][Full Text] [Related]
57. A novel nanocapsule delivery system to overcome intestinal degradation and drug transport limited absorption of P-glycoprotein substrate drugs.
Nassar T; Rom A; Nyska A; Benita S
Pharm Res; 2008 Sep; 25(9):2019-29. PubMed ID: 18581211
[TBL] [Abstract][Full Text] [Related]
58. Intestinal absorption of raltitrexed and evaluation of the effects of absorption enhancers.
Yu Y; Lu Y; Zhao X; Li X; Yin Z
Pharmazie; 2013 Sep; 68(9):732-43. PubMed ID: 24147341
[TBL] [Abstract][Full Text] [Related]
59. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.
Sha X; Fang X
Int J Pharm; 2004 Mar; 272(1-2):161-71. PubMed ID: 15019079
[TBL] [Abstract][Full Text] [Related]
60. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
